DMK Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.35 | £28.11 | 50.96% | 9 | £4.27B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.08 | $69.00 | 47.34% | 0 | $2.02B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.08 | $41.00 | 32.98% | 0 | $1.65B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$66.52 | $69.75 | 20.26% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$8.22 | $17.83 | 106.81% | 2 | $1.23B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$26.95 | $47.90 | 66.98% | 6 | $1.22B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$37.78 | $37.75 | 5.88% | 1 | $1.21B |
| BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | $10.00 | 16.46% | 0 | $577.05M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.37 | $6.33 | 167.06% | 0 | $305.89M |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$4.60 | $19.50 | 302.17% | 1 | $253.06M |
| EBS | Emergent BioSolutions | Outperform |
16
|
$1.93 | $5.00 | 159.07% | 0 | $101.11M |
| DCTH | Delcath Systems | Buy |
0
|
$5.40 | $19.25 | 279.63% | 1 | $99.65M |
| ASRT | Assertio Holdings | Buy |
8
|
$0.92 | $3.50 | 226.09% | 2 | $88.49M |
| DRRX | DURECT | Outperform |
9
|
$0.97 | $6.75 | 595.88% | 2 | $28.93M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | $8.50 | -100.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | Buy |
6
|
$1.00 | $4.63 | 413.00% | 0 | $21.53M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |